scispace - formally typeset
R

Robert W Eisinger

Researcher at National Institutes of Health

Publications -  25
Citations -  2012

Robert W Eisinger is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Pandemic & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 13, co-authored 23 publications receiving 1458 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

Henry Masur, +97 more
- 03 Sep 2002 - 
TL;DR: This fourth edition of the guidelines for preventing opportunistic infections (OIs) among persons infected with human immunodeficiency virus (HIV) is intended for clinicians and other health-care providers who care for HIV-infected persons.
Journal ArticleDOI

HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable.

TL;DR: The underlying science-based evidence supporting the Undetectable = Untransmittable (U = U) concept is examined and the behavioral, social, and legal implications associated with the acceptance are examined.
Journal ArticleDOI

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

Michael J. A. Reid, +83 more
- 30 Mar 2019 - 
TL;DR: The Commission recommends five priority investments to achieve a tuberculosis-free world within a generation, which answer the question of how countries with high-burden tuberculosis and their development partners should target their future investments.
Journal ArticleDOI

The Pathway to a Universal Influenza Vaccine

TL;DR: A workshop was convened in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them and to identify candidates for a universal influenza vaccine.
Journal ArticleDOI

Ending the HIV/AIDS Pandemic1.

TL;DR: The pathway to ending the HIV/AIDS pandemic will be difficult and will require aggressive implementation of the biomedical research advances that have been made in the areas of treatment and prevention; development of additional tools, such as a moderately effective HIV vaccine; and attention to critical behavioral and social determinants.